Hormones Don't Need to Make You Live Longer to Be Worth It

The New York Times Opinion piece discusses the current scarcity of estrogen patches, attributing the shortage to a surge in demand. The author argues that this increased interest is largely positive, reflecting a growing recognition of hormone therapy's value for quality of life rather than just longevity. Despite supply chain challenges, the article suggests that the benefits of managing menopausal symptoms and improving daily well-being justify the continued pursuit of these treatments. The piece serves as a commentary on shifting public perceptions regarding menopause care and the importance of prioritizing patient comfort over purely statistical health outcomes.